business
Own 500 Shares of Pfizer and JNJ and Here’s Your Annual Dividend Income
Key takeaways
- JNJ s 64th consecutive dividend increase to $1.34 quarterly is backed by a AAA-rated balance sheet and $19.7 billion in free cash flow.
- Pfizer s 6.8% yield reflects stock compression, with CEO Albert Bourla prioritizing the dividend over buybacks while Padcev jumped 39% in Q1 2026.
- Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Johnson & Johnson didn t make the cut.
Own 500 Shares of Pfizer and JNJ and Here’s Your Annual Dividend Income Vandita Jadeja Sun, June 21, 2026 at 10:30 PM GMT+7 4 min read JNJ PFE NVDA Quick Read 500 shares each of PFE and JNJ generate $3,540 in annual passive income on a $127,000 investment at a blended 2.79% yield.
JNJ s 64th consecutive dividend increase to $1.34 quarterly is backed by a AAA-rated balance sheet and $19.7 billion in free cash flow.
Pfizer s 6.8% yield reflects stock compression, with CEO Albert Bourla prioritizing the dividend over buybacks while Padcev jumped 39% in Q1 2026.
Article preview — originally published by Yahoo Finance. Full story at the source.
Read full story on Yahoo Finance →
More top stories
Also covered by
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop